A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging
Open Access
- 2 May 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 94 (10), 1420-1427
- https://doi.org/10.1038/sj.bjc.6603140
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PTK787/ZK 222584 Administered Twice Daily in Patients With Advanced CancerJournal of Clinical Oncology, 2005
- Molecular Imaging of Antiangiogenic AgentsThe Oncologist, 2005
- Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126Clinical Cancer Research, 2004
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I StudiesJournal of Clinical Oncology, 2003
- Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance ImagingJournal of Clinical Oncology, 2003
- Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysisNMR in Biomedicine, 2002
- DynamicT1Measurement Using Snapshot-FLASH MRIJournal of Magnetic Resonance, 1997
- Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imagingMagnetic Resonance in Medicine, 1996
- Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental conceptsMagnetic Resonance in Medicine, 1991
- Snapshot flash mri. applications to t1, t2, and chemical‐shift imagingMagnetic Resonance in Medicine, 1990